Pharmaids Pharmaceuticals Ltd. Announces Sale of Subsidiary Interest
Pharmaids Pharmaceuticals Limited announced the completion of a transaction involving its step-down subsidiary, Siri Labvivo Diet Private Limited, on March 27, 2026. Adita Bio Sys Private Limited, a material subsidiary of Pharmaids Pharmaceuticals, divested its shareholding in Siri Labvivo Diet Private Limited.As a result of this transaction, Siri Labvivo Diet Private Limited is no longer considered a subsidiary of Adita Bio Sys Private Limited, nor a step-down subsidiary of Pharmaids Pharmaceuticals.
The sale involved a consideration of Rs. 3,00,000 and was completed on March 27, 2026. The buyer, Mr. Shivakumar B G, is not affiliated with Pharmaids Pharmaceuticals or its group companies. The transaction does not qualify as a related party transaction.
Financial Contribution of Siri Labvivo Diet Private Limited (as of March 31, 2025):
| Particulars | Amount (Rs.) | Percentage (%) |
|---|---|---|
| Contribution to Consolidated Revenue | 14,11,220 | 0.73 |
| Contribution to Consolidated Net Worth | (89,11,119) | (1.62) |
The transaction did not occur outside of a scheme of arrangement, and no indicative disclosures related to amalgamation or merger were applicable.
Source:
Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.